Zobrazeno 1 - 10
of 17
pro vyhledávání: '"MAJA TOMIĆ PARADŽIK"'
Autor:
Valentina Živković, Tomislav Kurevija, Ivana Haršanji Drenjančević, Maja Bogdan, Maja Tomić-Paradžik, Jasminka Talapko, Domagoj Drenjančević
Publikováno v:
Southeastern European Medical Journal, Vol 2, Iss 1, Pp 12-19 (2018)
Aim: The goal of this research is to examine the biofilm forming ability of Staphylococcus aureus and Pseudomonas aeruginosa clinical isolates in different in vitro conditions using Meuller-Hinton and Luria-Bertani broths. Material and methods: 30
Externí odkaz:
https://doaj.org/article/dfd780c9624849af856adc2df62b3c6b
Autor:
Maja Abram, Domagoj Drenjančević, Maja Tomić Paradžik, Marko Vučković, Finka Štivić, Maja Bogdan
Publikováno v:
Infektološki glasnik. 40:113-119
Cilj : Prikaz slučaja bakterijemije, uzrokovane bakterijom Actinomyces sp., kod desetogodišnjeg dječaka s karioznim zubalom. Prikaz bolesnika: Prikazali smo dječaka koji je višekratno hospitaliziran zbog ponavljajućih febriliteta i povišenih u
Autor:
Branka Bedenić, Domagoj Drenjančević, Maja Tomić Paradžik, Aleksandra Presečki-Stanko, Jasminka Talapko, Jasminka Kopić, Gernot Zarfel
Publikováno v:
Microbial Drug Resistance. 25:696-702
The purpose of this study was to report the identification OXA-48 carbapenemase in seven extended-spectrum β-lactamase (ESBL)-positive Escherichia coli clinical isolates, fully susceptible to all carbapenems by disk diffusion and E-test methods, but
Autor:
Maja Tomić-Paradžik, Ivan Barišić, Vesna Elveđi-Gašparović, Zoran Herljević, Nataša Beader, Rick Conzemius, Branka Bedenić, Jasmina Vraneš, Marija Krilanović, Tomislav Meštrović
Publikováno v:
Folia Microbiologica
In recent years, a dramatic increase in the prevalence of Escherichia coli strains producing extended-spectrum β-lactamases (ESBLs) has been observed - both in the community and in healthcare settings. This multicentric study aimed to characterize E
Autor:
Finka Štivić, Maja Tomić Paradžik
Publikováno v:
Medicina Fluminensis. 54:329-333
Autor:
Maja, Tomić Paradžik, Domagoj, Drenjančević, Aleksandra, Presečki-Stanko, Jasminka, Kopić, Jasminka, Talapko, Gernot, Zarfel, Branka, Bedenić
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.). 25(5)
The purpose of this study was to report the identification OXA-48 carbapenemase in seven extended-spectrum β-lactamase (ESBL)-positive
Autor:
Domagoj Drenjančević, Tatjana Tot, Mirna Vranić-Ladavac, Arjana Tambić-Andrašević, Sanda Sardelić, Ana Benčić, Gernot Zarfel, Maja Bogdan, Daniela Bandić-Pavlović, Marina Bubonja-Šonje, Rick Conzemius, Amarela Lukić-Grlić, Lidija Žele Starčević, Marija Gužvinec, Vlasta Zujić Atalić, Mia Slade, Dijana Varda-Brkić, Slobodan Mihaljević, Branka Bedenić, Maja Tomić-Paradžik, Ivan Barišić
Publikováno v:
Journal of Medical Microbiology
Volume 67
Issue 8
Volume 67
Issue 8
PURPOSE: A dramatic increase in OXA-48 β-lactamase was observed recently not only in large hospital centres, but also in smaller suburban hospital centres in geographic areas bordering Croatia. The aim of the study was to analyse the epidemiology, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c6d69914c1152236fdb822736122b31
https://repository.medri.uniri.hr/islandora/object/medri:5296
https://repository.medri.uniri.hr/islandora/object/medri:5296
Autor:
Maja Tomić Paradžik
Clostridium difficile is a Gram-positive spore-forming anaerobe that can be found in the stomach and the intestines of healthy people. There are two forms of C. difficile bacteria – an active form that cannot survive in the environment for long per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::0385d27e76b54c3eb888f47e7e07a592
https://zenodo.org/record/1564546
https://zenodo.org/record/1564546
case of the first evidence of epidemic strain Clostridium difficile (027/NAP1 (BI) in a patient in Slavonia region (Eastern Croatia) is presented. Clostridium difficile infection presents the leading cause of the antibiotic-associated nosocomial diar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb9b88b59942698fa999f9e807749181
https://www.bib.irb.hr/869990
https://www.bib.irb.hr/869990
Autor:
Maja Tomić Paradžik, Jasminka Kopić
Publikováno v:
Disaster Medicine and Public Health Preparedness
Noninvasive ventilation (NIV) is a proved and effective therapeutic option for some patients with respiratory failure. During an epidemic, NIV can free up respirators and other intensive care unit equipment for patients with respiratory insufficiency